What's Behind Novartis' Disappointing Q2 Results
Novartis (NYSE: NVS) hasn't fared as well as some of its peers have so far in 2020. Shares of the big drugmaker rebounded from the stock market crash in February and March but have mainly been in a holding pattern since April.
The company had a potential catalyst on Tuesday, with Novartis announcing its second-quarter results before the market opened. However, there wasn't enough good news in those results to excite investors. Here are the highlights of Novartis' Q2 update.
Source Fool.com